Johnson & Johnson is a healthcare company focused on Innovative Medicine (pharmaceuticals) and MedTech following the separation of its consumer-health business. Drug pipeline, patent exposure, and litigation are key watch items.
With Secaura, you can ask about Johnson & Johnson's filings, financials, and ownership and get an answer that cites the exact source, so you can check it yourself.
How does J&J split revenue between Innovative Medicine and MedTech?
What patent expirations does Johnson & Johnson flag as risks?
What does J&J disclose about ongoing litigation?
How has J&J's free cash flow and dividend trended?
What are the growth drivers in J&J's MedTech segment?
What are the key risk factors in J&J's 10-K?
SEC filing Q&A
Ask about the 10-K, 10-Q, and 8-K. Every answer cites the exact filing section it came from.
Five-year XBRL financials
Revenue, margins, EPS, cash flow, and CapEx, with year-over-year change on each.
Institutional ownership
Form 13F holdings that show which institutions are building or trimming positions.
Insider transactions
Form 4 filings that track buying and selling by executives and directors.
Competitive-moat signals
Computed indicators of a durable competitive advantage, drawn from the filings.
Open Secaura, select JNJ, and ask in plain English, like "How does J&J split revenue between Innovative Medicine and MedTech?". Secaura pulls the exact sections of JNJ's 10-K and 10-Q that answer you and returns a cited answer you can check against the source.
Secaura shows JNJ institutional ownership from Form 13F filings and insider transactions from Form 4 filings, next to its filing Q&A, so you can see who is buying and selling in one place.
Five years of XBRL financials (revenue, margins, EPS, cash flow, and more), plus JNJ's 10-K, 10-Q, and 8-K filings, institutional and insider activity, and competitive-moat signals. Every answer cites the filing it came from.
Yes. JNJ is available on the free tier, which includes cited SEC filing Q&A, five-year financials, and ownership data, with a daily question limit. Sign in with Google to start.
Ask Secaura about Johnson & Johnson
Cited answers from real SEC filings. Free to start, no credit card.
Try it free